摘要
目的对头孢曲松钠与头孢呋辛钠治疗儿童下呼吸道感染进行药物经济学分析,为临床提供用药参考方案。方法采用回顾性研究,运用药物经济学的成本-效果分析方法对头孢曲松钠与头孢呋辛钠治疗儿童下呼吸道感染进行评价。结果头孢曲松钠与头孢呋辛钠治疗儿童下呼吸道感染的总有效率分别为95%和97%,二者差异无统计学意义(P>0.05);治疗成本分别为1336.40元和1880.30元,差异有统计学意义(P<0.05)。结论头孢曲松钠比头孢呋辛钠经济,符合药物经济学原则。
Objective Pharmacoeconomics analysis was used to help clinic drug administration in treating children＇s suber rehpirapory infection. Methods Retiospective study was used to analyze the cost and effectiveness. Results These two drugs were both efficient （effective rate is 95% and 97%） and there was no statistically significant difference （P〉 0.05）. The total cost of two drugs were 1 336.40 yuan and 1 880.30 yuan respectively;and there was significantly dif ferent （P〈0.05）. Coclusion It was economical to take ceftriaxone sodium rather than cefuroxime sodium.
出处
《实用医技杂志》
2006年第16期2777-2778,共2页
Journal of Practical Medical Techniques
关键词
头孢曲松钠
头孢呋辛钠
药物经济学
下呼吸道感染
儿童
Ceftriaxone sodium
Cefuroxime
Pharmacoeconomics
Suber rehpirapory infection
Children
